ID: hypothesis-h-16ee87a4
Hypothesis
Astrocytic Connexin-43 Upregulation Enhances Neuroprotective Mitochondrial Donation
Pharmacological enhancement of connexin-43 expression in astrocytes increases tunneling nanotube formation and mitochondrial transfer to damaged neurons, leveraging natural mitochondrial donation capacity for neuroprotection.
EvidencePending (0%)📖 26 cit🗣 3 debates✓ 4 support✗ 3 oppose
✓ All Quality Gates Passed
🧪 Overview
Pharmacological enhancement of connexin-43 expression in astrocytes increases tunneling nanotube formation and mitochondrial transfer to damaged neurons, leveraging natural mitochondrial donation capacity for neuroprotection.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
graph TD
A["Oxidative Stress and Neuronal Damage"] -->|"triggers"| B["Astrocyte Activation"]
B -->|"upregulates"| C["GJA1 Gene Expression"]
C -->|"increases"| D["Connexin-43 Protein Synthesis"]
D -->|"enhances"| E["Gap Junction Formation"]
E -->|"facilitates"| F["Astrocyte-Astrocyte Communication"]
F -->|"coordinates"| G["Tunneling Nanotube Assembly"]
D -->|"stabilizes"| G
G -->|"enables"| H["Mitochondrial Transfer Machinery"]
H -->|"transports"| I["Healthy Mitochondria to Neurons"]
I -->|"restores"| J["Neuronal ATP Production"]
I -->|"reduces"| K["Neuronal Ca2+ Overload"]
J -->|"improves"| L["Synaptic Function"]
K -->|"prevents"| M["Neuronal Apoptosis"]
L -->|"promotes"| N["Neuroprotection"]
M -->|"contributes to"| N
O["Connexin-43 Modulators"] -->|"therapeutic target"| D
classDef mechanism fill:#4fc3f7,color:#0d0d1a
classDef pathology fill:#ef5350,color:#0d0d1a
classDef therapy fill:#81c784,color:#0d0d1a
classDef outcome fill:#ffd54f,color:#0d0d1a
classDef genetics fill:#ce93d8,color:#0d0d1a
class A,K pathology
class C,D,E,F,G,H genetics
class B,I,J,L mechanism
class O therapy
class M,N outcome⚖️ Evidence
⚖️ Evidence Matrix3 supports3 contradicts
Supports
Astrocytes transfer functional mitochondria to neurons via tunneling nanotubes containing connexin-43
Supports
Connexin-43 deficiency reduces astrocyte-to-neuron mitochondrial transfer and worsens neuronal survival
Supports
Tunneling nanotubes facilitate intercellular organelle transfer including mitochondria
Contradicts
Connexin-43 knockout mice show enhanced rather than impaired mitochondrial transfer in some contexts
Contradicts
Tunneling nanotubes are primarily F-actin based structures, with connexin involvement being secondary and controversial
Contradicts
Excessive connexin-43 expression leads to cellular toxicity and disrupted calcium homeostasis
📖 Linked Papers (24)Export BibTeX ↗
Prenatal lipopolysaccharide exposure programs cardiac fibrosis via dysregulating of connexin 43 in offspring rats.
Molecular medicine reports (2026) · PubMed:41789580 ↗
6 figures

Figure 1.
BW of offspring rats from 1-day to 16-week-old (A). Heart damages in offspring at the age of 8 and 16 weeks, including the ratios (B) LVW/BW, (C) HW/BW and (D) ...

Figure 2.
Histopathological observation of LV in 8- and 16-week-old offspring rats. (A) Hematoxylin and eosin staining. (B) Masson trichrome staining and (C) CVF. Data ar...
Connexin43 Deficiency Leads to Ventricular Arrhythmias by Reprogramming Proline Metabolism.
Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2026) · PubMed:41618855 ↗
7 figures

FIGURE 1
GJA1 is identified as one of the crucial genes for ventricular arrhythmias. (A) Venn diagram of the ventricular arrhythmia (VA) putative genes (PVC: premature ...

FIGURE 2
Connexin43 knockout causes arrhythmias and abnormal action potential properties in induced pluripotent stem cell–derived cardiomyocytes. (A) Schematic diagram o...
Harlequin syndrome associated with thoracic epidural anaesthesia.
Anaesthesia reports (2022) · PubMed:35118419 ↗
1 figure
Figures
Figures available at source paper (no open-access XML found).
Transmission dynamics of a linear vanA-plasmid during a nosocomial multiclonal outbreak of vancomycin-resistant enterococci in a non-endemic area, Japan.
Scientific reports (2021) · PubMed:34285270 ↗
8 figures

Figure 1
Minimum inhibitory concentration of vancomycin and teicoplanin for vancomycin-resistant Enterococcus faecium isolates during the outbreak. According to the cr...

Figure 2
Dendrogram of pulsotypes in pulsed-field gel electrophoresis and sequence types in multilocus sequence typing among vancomycin-resistant Enterococcus faecium ...
Astrocyte Networks as Therapeutic Targets in Glaucomatous Neurodegeneration.
Cells (2021) · PubMed:34199470 ↗
3 figures

Figure 1
Schematic cross section of the rodent optic nerve head demonstrating Cx43 gap junctions and hemichannels. Optic nerve astrocytes (dark green) are arranged in a ...

Figure 2
A working model of the role of Cx43 in neurologic disease. A pathologic insult to neural tissue ( a ) causes an increased expression of Cx43 ( b ). Cx43 connexo...
High resolution spatiotemporal patterns of seawater temperatures across the Belize Mesoamerican Barrier Reef.
Scientific data (2020) · PubMed:33199700 ↗
3 figures

Fig. 1
Map of logger deployment sites in Belize.

Fig. 2
Cross-sectional view of Carrie Bow Caye describing back reef and the two fore reefs in this area: inner fore reef and outer fore reef.
Cx43 modulates malignant phenotypes in bladder cancer cells via the c-Src/PTEN/FAK axis.
Journal of molecular histology (2026) · PubMed:41910821 ↗
No figures
Hypoxia Increases Connexin46 and Connexin43 Levels in KNS-42 Glioblastoma Cells.
International journal of molecular sciences (2026) · PubMed:41898710 ↗
No figures
A Single-Cell Transcriptomic Atlas Elucidates a Microglial Gene Signature Linking Ferroptosis to Mitochondrial Dysfunction in Epilepsy.
Journal of inflammation research (2026) · PubMed:41884157 ↗
No figures
Danggui Sini decoction attenuates intervertebral disc degeneration by regulating ferroptosis in nucleus pulposus cells via the GJA1/cGAS/STING signaling axis.
International immunopharmacology (2026) · PubMed:41812505 ↗
No figures
Increased Expression of Connexin 43 Promotes Wnt/β-Catenin Signaling and the Progression of Temporomandibular Joint Osteoarthritis.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology (2026) · PubMed:41757775 ↗
No figures
📙 Related Wiki Pages (15)
NSF GenegeneNSF ProteinproteinFER GenegeneGJA1geneGJA1 ProteinproteinNeurodegenerationdiseaseAlibaba Tongyi Qianwen-Bio (Chinese Biomai_toolAlzheimer's DiseasediseaseneuroimaginggeneralAmyotrophic Lateral SclerosisredirectBiogencompanyDiagnosticsindexBlood-Brain BarriercellCompaniesindexMeningeal Fibroblastscell
🏥 Translation
🧬 3D Protein Structure — GJA1
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for GJA1 from GTEx v10.
💉 Clinical Trials (5)Relevance: 38%
0
Active
Active
0
Completed
Completed
1,240
Total Enrolled
Total Enrolled
PHASE1
Highest Phase
Highest Phase
UNKNOWN·NCT04887675 · University of Novi Sad
120 enrolled · 2021-05-01 · → 2022-06-01
Since the HIV changed its course to the chronic disease, high incidence of metabolic syndrome both in HIV positive and negative subjects has become an issue. Given the successful peripheral suppressio
HIV I Infection HIV Associated Lipodystrophy Metabolic Syndrome
MRI
ENROLLING_BY_INVITATION·NCT06875739 · Fondazione Don Carlo Gnocchi Onlus
310 enrolled · 2025-02-14 · → 2026-10-01
The aim of the study is to validate a salivary test that allows for rapid and accurate objective diagnosis in the context of neurodegenerative diseases, a complex of diseases that includes Alzheimer's
Neurodegenerative Disorders Parkinson Disease Alzheimer Disease
RECRUITING·NCT00029965 · National Human Genome Research Institute (NHGRI)
200 enrolled · 2002-02-06
Study description:
This is a natural history study that will evaluate any patient with enzyme or DNA confirmed GM1 or GM2 gangliosidosis, sialidosis or galactosialidosis. Patients may be evaluated ev
Neurological Regression Myoclonus Cherry Red Spot
COMPLETED·NCT04281186 · Hospital Universitari Vall d'Hebron Research Institute
510 enrolled · 2020-11-16 · → 2024-12-12
The retina shares similar embryologic origin, anatomical features and physiological properties with the brain and hence offers a unique and accessible "window" to study the correlates and consequences
Retinal Function Cognitive Dysfunction Microperimetry
UNKNOWN·NCT04248270 · Chang Gung Memorial Hospital
100 enrolled · 2020-02-20 · → 2023-08-17
Dementia is a clinical syndrome which characterized by progressive cognitive impairment, behavior disturbance and dysfunction of daily activity. In aging population, Alzheimer's dementia (AD) is the m
Alzheimer's Disease Vascular Dementia Dementia
18F-PM-PBB3
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for GJA1.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
💰 Estimated Development
Cost
$0
Timeline
2.0 years
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▼ 1.0%
Volatility
Medium
0.0470
Events (7d)
5
Price History
▼33.2%💾 Resource Usage
LLM Tokens
39,356
$0.2361
Total Cost
$0.2361
🔮 Predictions
🔎 Predictions vs Observations5 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| If hypothesis is true, intervention require a multi-tiered experimental approach combining in vitro and in vivo methodologies | require a multi-tiered experimental approach combining in vitro and in vivo methodologies | — no observation — | pending | 0.60 |
| If hypothesis is true, intervention utilize primary astrocyte-neuron co-cultures to establish proof-of-concept | utilize primary astrocyte-neuron co-cultures to establish proof-of-concept | — no observation — | pending | 0.60 |
| If hypothesis is true, intervention require careful optimization of therapeutic interventions | require careful optimization of therapeutic interventions | — no observation — | pending | 0.60 |
| If hypothesis is true, intervention be therapeutically exploited in neurodegenerative diseases where mitochondrial dysfunction is a central pathological feature | be therapeutically exploited in neurodegenerative diseases where mitochondrial dysfunction is a central pathological feature | — no observation — | pending | 0.60 |
| If hypothesis is true, intervention amplify the natural mitochondrial donation capacity represents a novel therapeutic strategy that leverages the brain's endogenous repair mechanisms | amplify the natural mitochondrial donation capacity represents a novel therapeutic strategy that leverages the brain's endogenous repair mechanisms | — no observation — | pending | 0.60 |
🔮 Falsifiable Predictions (5)
pendingconf 60%
If hypothesis is true, intervention require a multi-tiered experimental approach combining in vitro and in vivo methodologies
Predicted outcome: require a multi-tiered experimental approach combining in vitro and in vivo methodologies
Falsification: Intervention fails to require a multi-tiered experimental approach combining in vitro and in vivo methodologies
pendingconf 60%
If hypothesis is true, intervention utilize primary astrocyte-neuron co-cultures to establish proof-of-concept
Predicted outcome: utilize primary astrocyte-neuron co-cultures to establish proof-of-concept
Falsification: Intervention fails to utilize primary astrocyte-neuron co-cultures to establish proof-of-concept
pendingconf 60%
If hypothesis is true, intervention require careful optimization of therapeutic interventions
Predicted outcome: require careful optimization of therapeutic interventions
Falsification: Intervention fails to require careful optimization of therapeutic interventions
pendingconf 60%
If hypothesis is true, intervention be therapeutically exploited in neurodegenerative diseases where mitochondrial dysfunction is a central pathological feature
Predicted outcome: be therapeutically exploited in neurodegenerative diseases where mitochondrial dysfunction is a central pathological feature
Falsification: Intervention fails to be therapeutically exploited in neurodegenerative diseases where mitochondrial dysfunction is a central pathological feature
pendingconf 60%
If hypothesis is true, intervention amplify the natural mitochondrial donation capacity represents a novel therapeutic strategy that leverages the brain's endogenous repair mechanisms
Predicted outcome: amplify the natural mitochondrial donation capacity represents a novel therapeutic strategy that leverages the brain's endogenous repair mechanisms
Falsification: Intervention fails to amplify the natural mitochondrial donation capacity represents a novel therapeutic strategy that leverages the brain's endogenous repair mechanisms
Related Entities
▸Metadata
| status | proposed |
| disease | neurodegeneration |
| target_gene | GJA1 |
| target_pathway | None |
| _schema_version | 1 |
| composite_score | 0.6788 |
| last_experiment_id | exp-cbd92ac0-dcd3-4d4c-afaa-b9c2fe8b4d3f |
| last_experiment_result | confirmed |
| last_experiment_confidence | 0.88 |
📊 Evidence Profile
Foundational
Evidence Balance
+0%
Certainty
100%
Debates
0
Incoming
972
Outgoing
144
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.